Coherus and Junshi Biosciences Expand Immuno-Oncology Collaboration to Include TIGIT-Targeted Antibody
January 10, 2022 07:30 ET
|
Coherus BioSciences, Inc.
• Coherus and Junshi Biosciences plan to evaluate the toripalimab + JS006 combinationin clinical trials in multiple tumor types • Combinations of PD-1 + TIGIT inhibitors have potential to expand...
Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results
January 09, 2022 14:00 ET
|
Emergent BioSolutions
Expects a re-baseline of operations with stable revenue contributions from core products and services business in 2022, guiding to total revenues of $1.45 billion at the midpoint and Adjusted EBITDA...
Cullinan Oncology to Present at Upcoming Virtual Investor Conferences
January 05, 2022 09:00 ET
|
Cullinan Oncology, Inc.
CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today announced that it will present at the following virtual healthcare conferences in...
Emergent BioSolutions to Participate in Investor Conferences
January 03, 2022 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
ObsEva SA to Participate in JP Morgan Virtual Healthcare Conference January 11 - 14, 2021
January 07, 2021 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – January 7, 2021 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s...
Mettler-Toledo International Inc. Announces Webcast of Presentation at the Virtual J.P. Morgan Healthcare Conference
January 05, 2021 16:15 ET
|
Mettler-Toledo, LLC
Columbus, OH, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) today announced the webcast of its presentation at the virtual J.P. Morgan Healthcare Conference on...
Vir Biotechnology to Present at 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021 08:00 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today...
Emergent BioSolutions to Participate in Investor Conferences
January 04, 2021 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
DEADLINE ALERT for LVS, IPHA, JPM, and FAF: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 21, 2020 11:30 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 21, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for LVS, IPHA, JPM, and FAF: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
December 16, 2020 11:00 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...